In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Relatório de Atividades 2024 – Brasil
The Future of Health Financing in Africa: The Role of Health Taxes
RESET Alcohol Initiative Case Study: Media Campaign Resonates with the Public in Mexico
RESET Alcohol Initiative Case Study: A Historic Win for Alcohol Policy in Brazil
Effects of Heat on Early Childhood Development
Blood Lead Surveillance of Children and Pregnant Women in Tamil Nadu, India
Sportswashing through Media: Coca-Cola’s Olympic Play – A Research Report
What’s in Our Food?
Mais Dados Mais Saúde
More Data, Better Health – Primary Health Care